All appeals dismissed; finding of anti-competitive bid-rigging upheld under Sections 3(3)(c), 3(3)(d) read with 3(1); cease-and-desist and total-turno...
Central Government notifies 11.541-hectare Special Economic Zone for semiconductor manufacturing; Approval Committee constituted, ICD status effective...
Government appoints National Customs Targeting Centre-Passenger director as customs officer with powers under PNR Regulations, 2022 and Sections 30A, ...
The CESTAT allowed the appellant's appeal, holding that the exemption notification and IGST rate notification must be given a purposive interpretation to cover technologically advanced NAAT diagnostic kits for HIV as performing the same statutory purpose as antibody kits. The impugned order denying benefit of the Exemption Notification and reduced IGST was set aside; the imported kits are held eligible for exemption from basic customs duty and for levy of IGST at 5% as specified in List 1. The tribunal declined to decide tariff classification given the grant of exemption. Appeal allowed and impugned order dated 20.12.2022 quashed.
The CESTAT allowed the appellant's appeal, holding that the exemption notification and IGST rate notification must be given a purposive interpretation to cover technologically advanced NAAT diagnostic kits for HIV as performing the same statutory purpose as antibody kits. The impugned order denying benefit of the Exemption Notification and reduced IGST was set aside; the imported kits are held eligible for exemption from basic customs duty and for levy of IGST at 5% as specified in List 1. The tribunal declined to decide tariff classification given the grant of exemption. Appeal allowed and impugned order dated 20.12.2022 quashed.
Note: It is a system-generated summary and is for quick reference only.